| Application no. and date | 19185175.7 (espacenet) (Federated) (European Patent Register), 20131217 | | Patent/reg. no. and date | DK/EP 3575326, 20220413 | | Publication date | 20191204 | | Priority no. and date | US 201261738008 P, 20121217 | | EP pub. no. and date |
EP 3575326 20191204 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York,
NY 10001-2192, US | | Applicant ref. no. | V441046DK00 | | Inventor | UGER, Robert Adam, 20 Reditt Court
Richmond Hill, Ontario L4C 7S4, CA,
SLAVOVA-PETROVA, Penka Slavtcheva, 1207-2261 Lake Shore Blvd West
Toronto, Ontario M8V 3X1, CA,
PANG, Xinli, 190 Mountainash Road
Brampton, Ontario L6R 3H1, CA | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/16 (2006.01) , A61K 38/45 (2006.01) , A61P 35/02 (2006.01) , C07K 14/705 (2006.01) , C07K 16/00 (2006.01) , C07K 19/00 (2006.01) , C12N 15/62 (2006.01) , A61K 38/00 (2006.01) | | Title | Behandling af CD47+ sygdomsceller med SIRP ALFA-FC-fusioner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
